Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
1 Correction to: Clinical Pharmacokinetics https://doi.org/10.1007/s40262-018-0721-y
Introduction section, para 3, lines 2–4 which previously read:
In an open-label, phase I/II, dose-finding trial (ClinicalTrials.gov identifier: NCT02418455),…
In an open-label, phase I/II, dose-finding trial (ClinicalTrials.gov identifier: NCT01856218),…
The original article was corrected.